Physician profile
Roy Cohen
NPI 1780609735
$5,806.07
in general payments reported to CMS, 2019-2025
17 companies · $580 in 2025
The $580 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,150 · 2020: $338 · 2021: $2,056 · 2022: $522 · 2023: $583 · 2024: $577 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,619.87 | 2019-2025 | Precision 1, Total30, Precision7 |
| Coopervision INC. | $1,440.92 | 2019-2025 | Myday Contact Lens, Synergeyes Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $328.77 | 2022-2025 | Xiidra, Miebo, Infuse |
| Sun Pharmaceutical Industries INC. | $234.94 | 2022-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $208.70 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $199.91 | 2019-2025 | |
| Abbvie INC. | $139.88 | 2022-2024 | Lumigan |
| Oyster Point Pharma, INC. | $114.41 | 2022-2025 | Ryzumvi, Tyrvaya |
| Novartis Pharmaceuticals Corporation | $110.93 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $81.27 | 2024-2025 | Xdemvy |
| Allergan, INC. | $73.49 | 2019-2022 | |
| Shire North American Group INC | $71.16 | 2019 | |
| Sight Sciences, INC. | $71.02 | 2022-2023 | Tearcare System |
| Biotissue Holdings INC. | $54.51 | 2025 | |
| Kala Pharmaceuticals, INC. | $24.44 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Alcon Research LLC | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.